Corticosteroids and fetal vasculature: Effects of hydrocortisone, dexamethasone and betamethasone on human umbilical artery

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 109, Issue 10, 2002, Pages 1126-1131

  Potter, S M ^a   Dennedy, M C ^a   Morrison, J J ^a  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CORTICOSTEROID; DEXAMETHASONE; HYDROCORTISONE;

ADOLESCENT; ARTERY TONE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSECTION; DRUG EFFECT; FEMALE; HUMAN; IN VITRO STUDY; PHYSIOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SAMPLING; UMBILICAL ARTERY; UNIVERSITY HOSPITAL; VASCULARIZATION;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS; BETAMETHASONE; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FREE RADICAL SCAVENGERS; GESTATIONAL AGE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; PREGNANCY; PROSPECTIVE STUDIES; SEROTONIN; UMBILICAL ARTERIES; VASCULAR RESISTANCE;

EID: 0036805335     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-0328(02)01940-7     Document Type: Article

References (30)

1. Goldenberg R.L., Rouse D.J. Prevention of premature birth. N Engl J Med. 339:1998;313-320.
2. Morrison J.J., Rennie J.M. Clinical, scientific and ethical aspects of fetal and neonatal care at extremely preterm periods of gestation. Br J Obstet Gynaecol. 104:1997;1331-1350.
3. Joseph K.S., Kramer M.S., Marcoux Set al. Determinants of preterm birth rates in Canada from 1981 through 1983 and from 1992 through 1994. N Engl J Med. 339:1998;1434-1439.
4. Liggins G.C., Howie R.N. A controlled trial of antepartum corticosteroid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 50:1972;515-525.
5. Crowley P., Chalmers I., Keirse M.J. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. [see comments] Br J Obstet Gynaecol. 97:1990;11-25.
6. Crowley P. Prophylactic corticosteroids for preterm birth. [Cochrane Review] Cochrane Library. (3):2001;. Oxford.
7. Kay H.H., Bird I.M., Coe C.L., Dudley D.J. Antenatal steroid treatment and adverse fetal effects: what is the evidence? J Soc Gynecol Invest. 7:2000;269-278.
8. Walfisch A., Hallak M., Mazor M. Multiple courses of antenatal steroids: risks and benefits. Obstet Gynecol. 98:2001;491-497.
9. Dawes G.S., Serra-Serra V., Moulden M., Redman C.W. Dexamethasone and fetal heart rate variation. Br J Obstet Gynaecol. 101:1994;675-679. August.
10. Derks J.B., Mulder E.J., Visser G.H. The effects of maternal betamethasone administration on the fetus. Br J Obstet Gynaecol. 102:1995;40-46. January.
11. Magee L.A., Dawes G.S., Moulden M., Redman C.W. A randomised controlled comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. Br J Obstet Gynaecol. 104:1997;1233-1238. November.
12. Wallace E.M., Baker L.S. Effect of antenatal betamethasone administration on placental vascular resistance. Lancet. 353:1999;1404-1407.
13. Chitrit Y., Caubel P., Herrero R., Schwinte A.L., Guillaumin D., Boulanger M. Effects of maternal dexamethasone administration on fetal Doppler flow velocity waveforms. Br J Obstet Gynaecol. 107:2000;501-507. April.
14. Piazze J.J., Anceschi M.M., La Torre R., Amici F., Maranghi L., Cosmi E.V. Effect of antenatal betamethasone therapy on maternal-fetal Doppler velocimetry. Early Hum Dev. 60:2001;225-232.
15. Clifton V.L., Read M.A., Leitch IMet al. Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation. J Clin Endocrinol Metab. 76:1994;666-669.
16. Fowler N.O., Chou D.H. Potentiation of smooth muscle contraction by adrenal steroids. Circ Res. 9:1961;153-156.
17. Whitworth J.A., Connell J.M.C., Lever A.F., Fraser R. Pressor responsiveness in steroid-induced hypertension in man. Clin Exp Pharmacol Physiol. 13:1986;353-358.
18. Ullian M.E. The role of corticosteroids in the regulation of vascular tone. Cardiovasc Res. 41:1999;55-64.
19. Miyahara H., Imayama S., Hori Y., Suzuki H. Cellular mechanisms of the steroid-induced vascular responses in the rabbit ear artery. Gen Pharmacol. 24:1993;1155-1162.
20. Walker B.R., Williams B.C. Corticosteroids and vascular tone: mapping the messenger maze. Clin Sci. 82:1992;597-605.
21. Kornel L., Nelson W.A., Manisundaram B., Chigurupati R., Hayashi T. Mechanism of the effects of corticosteroids and mineralocorticoids on vascular smooth muscle contractility. Steroids. 58(12):1993;580-587.
22. Brem A.S., Bina R.B., Mehta S., Marshall J. Corticosteroids inhibit the expression of calcium-dependent potassium channels in vascular smooth muscle. Mol Genet Metab. 67(1):1999;53-57.
23. Nambi P., Pullen M., Wu H.L., Nuthulaganti P., Elshourbagy N., Kumar C. Dexamethasone down-regulates the expression of endothelin receptor in vascular smooth muscle cells. J Biol Chem. 267(27):1992;19,555-19,559.
24. Clifton V.L., Read M.A., Leitch I.M., Boura A.L.A., Robinson P.J., Smith R. Corticotrophin-releasing hormone-induced vasodilation in the human fetal placental circulation. J Clin Endocrinol Metab. 79(2):1994;666-669.
25. Marinoni E., Korbrits C., Di Iorio R., Cosmi E.V., Challis J.R.G. Effect of betamethasone in vivo on placental corticotrophin-releasing hormone in human pregnancy. Am J Obstet Gynecol. 178:1998;770-778.
26. Boersma J.L., Janzen K.M., Oliveira L., Crankshaw D.J. Characterization of excitatory prostanoid receptors in the human umbilical artery in vitro. Br J Pharmacol. 128:1999;1505-1512.
27. Bertrand C., St-Louis J. Reactivities to serotonin and histamine in umbilical and placental vessels during the third trimester after normotensive pregnancies and pregnancies complicated by preeclampsia. Am J Obstet Gynecol. 180:1999;650-659.
28. Haugen G. The influence of ciclosporine A on the vasoactive effects of serotonin in in vitro perfused human umbilical arteries. Early Hum Dev. 67:2002;69-77.
29. Wild S.M. Betamethasone in threatened preterm labour. Lancet. 358:2001;1017.
30. Ballard P.L., Ballard R.A. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol. 173:1995;254-262.